AIM ImmunoTech (AIM) Assets Average (2018 - 2025)
Historic Assets Average for ImmunoTech (AIM) over the last 10 years, with Q3 2025 value amounting to $4.8 million.
- ImmunoTech's Assets Average fell 6716.04% to $4.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $4.8 million, marking a year-over-year decrease of 6716.04%. This contributed to the annual value of $14.0 million for FY2024, which is N/A changed from last year.
- According to the latest figures from Q3 2025, ImmunoTech's Assets Average is $4.8 million, which was down 6716.04% from $5.2 million recorded in Q2 2025.
- In the past 5 years, ImmunoTech's Assets Average ranged from a high of $30.7 million in Q3 2023 and a low of $4.8 million during Q3 2025
- Over the past 3 years, ImmunoTech's median Assets Average value was $14.7 million (recorded in 2024), while the average stood at $14.6 million.
- In the last 5 years, ImmunoTech's Assets Average tumbled by 5233.58% in 2024 and then tumbled by 6747.43% in 2025.
- ImmunoTech's Assets Average (Quarter) stood at $23.6 million in 2023, then crashed by 53.02% to $11.1 million in 2024, then tumbled by 56.65% to $4.8 million in 2025.
- Its Assets Average was $4.8 million in Q3 2025, compared to $5.2 million in Q2 2025 and $7.4 million in Q1 2025.